The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease
Open accessAbstract
OBJECTIVE: A workgroup commissioned by the Alzheimer's Association (AA) and the National Institute on Aging (NIA) recently published research criteria for preclinical Alzheimer disease (AD). We performed a preliminary assessment of these guidelines. METHODS: We employed Pittsburgh compound B positron emission tomography (PET) imaging as our biomarker of cerebral amyloidosis, and (18) fluorodeoxyglucose PET imaging and hippocampal volume as biomarkers of neurodegeneration. A group of 42 clinically diagnosed AD subjects was used to create imaging biomarker cutpoints. A group of 450 cognitively normal (CN) subjects from a population-based sample was used to develop cognitive cutpoints and to assess population frequencies of the different preclinical AD stages using different cutpoint criteria. RESULTS: The new criteria subdivide the preclinical phase of AD into stages 1 to 3. To classify our CN subjects, 2 additional categories were needed. Stage 0 denotes subjects with normal AD biomarkers and no evidence of subtle cognitive impairment. Suspected non-AD pathophysiology (SNAP) denotes subjects with normal amyloid PET imaging, but abnormal neurodegeneration biomarker studies. At fixed cutpoints corresponding to 90% sensitivity for diagnosing AD and the 10th percentile of CN cognitive scores, 43% of our sample was classified as stage 0, 16% stage 1, 12 % stage 2, 3% stage 3, and 23% SNAP. INTERPRETATION: This cross-sectional evaluation of the NIA-AA criteria for preclinical AD indicates that the 1-3 staging criteria coupled with stage 0 and SNAP categories classify 97% of CN subjects from a population-based sample, leaving only 3% unclassified. Future longitudinal validation of the criteria will be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Initial studies in this emerging area have identified subgroups of older adults with subtle cognitive decline that do not conform to expected patterns and investigators have designated them as Suspected Non-Alzheimer Pathology (SNAP) and Unclassified groups [51, 52].”
From Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“Our hypothesis, therefore, can accommodate a growing realization that for many subjects with suspected AD, or who have an increased risk of developing AD, what are currently considered downstream biomarker changes potentially precede upstream biomarker changes [206-213].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [212]
In the citing paper
“Yet, this finding is in line with recent studies showing that AD-type atrophy and/or hypometabolism can be found in both Aβ-negative healthy controls (Jack et al., 2012) and Aβ-negative MCI patients (Prestia et al., 2013).”
From Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia (2013) · cites this paper as Jack et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Tunis (2003) · doi:10.1001/jama.290.12.1624 · Cited by 1,724
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 601
Clinical implications of the new diagnostic guidelines for dementia.
Howe, E. G. (2013) · Europe PMC (PubMed Central) · Cited by 3
The Future of Cognitive Screening in Neurodegenerative Diseases
Umfleet, L. G., Bilder, R. M., Loring, D. W., Thames, A. D., Hampstead, B. M., Bauer, R. M., Drane, D. L., & Cavanagh, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221077 · Cited by 3
Delvenne, A., Gobom, J., Reus, L. M., Dobričić, V., ten Kate, M., Schindler, S. E., Ramakers, I. H. G. B., Tijms, B. M., Vandenberghe, R. R., Schaeverbeke, J. M., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf253 · Cited by 3
At the crossroads of preclinical AD and normal brain ageing
Okonkwo, O. C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70207-8 · Cited by 3
Nonamyloid Pet Biomarkers and Alzheimer'S Disease: Current and Future Perspectives
Schilling, L. P., Leuzy, A., Zimmer, E. R., Gauthier, S. G., & Rosa‐Neto, P. (2014) · Future Neurology · doi:10.2217/fnl.14.40 · Cited by 4
Preventing Dementia in Older Cardiovascular Patients
Kuller, L. H., & López, O. L. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0401-x · Cited by 3
UPDATE ON PREVENTION TRIALS IN ALZHEIMER’S DISEASE
Vellas, B. J. (2014) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2014.30 · Cited by 3
Fischer, F. U., Initiative, A. D. N., Wolf, D. G. F., & Fellgiebel, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170147 · Cited by 3
Amyloid Imaging in Dementia and Neurodegenerative Disease
Ponisio, M. R., Iranpour, P., & Benzinger, T. L. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_11 · Cited by 4
Hiraoka, T. (2019) · Neurocase · doi:10.1080/13554794.2019.1599026 · Cited by 3
Preclinical Biomarkers in Alzheimer Disease
Resnick, S. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2462 · Cited by 3
Searching biomarkers for mental disorders—lessons from Alzheimer’s disease
Maier, W. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0732-3 · Cited by 3
Yu, L., Wang, T., Hansson, O., Janelidze, S., Lamar, M., Arfanakis, K., Bennett, D. A., Schneider, J. A., & Boyle, P. A. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200291 · Cited by 2
Yin, Z., Li, Y., Zhang, X., Xia, M., Chen, Z., Zhao, L., & Liang, F. (2022) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2022.102133 · Cited by 3
Haas, A.-L., Olm, P., Utz, J., Siegmann, E.-M., Spitzer, P., Florvaag, A., Schmidt, M. A., Doerfler, A., Lewczuk, P., Kornhuber, J., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1121500 · Cited by 2
Zeydan, B., & Kantarci, K. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.06.015 · Cited by 2
Self-citationKepe, V. (2013) · PET Clinics · doi:10.1016/j.cpet.2013.08.002 · Cited by 2
An Emerging Model of Word Retrieval in Preclinical Alzheimer ’s Disease
Kljajević, V. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000225 · Cited by 2
Imaging the ageing brain: identifying early disease or opening Pandora's box?
Schott, J. M. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30116-3 · Cited by 2
A Note on Changing Approach to Diagnosis of Alzheimer’s Disease
Tartaglione, A., & Sette, M. D. (2014) · EMJ Neurology · doi:10.33590/emjneurol/10310003 · Cited by 2
Huang, S., Zhu, J., Shen, X., Xu, W., Ma, Y., Li, H., Dong, Q., Tan, L., & Yu, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200059 · Cited by 2
Kimura, Y., Kato, T., Ito, K., & Ichise, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-39457-8_4 · Cited by 2
Neurodegenerative Disorders: Classification and Imaging Strategy
Haller, S., Garibotto, V., & Barkhof, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-68536-6_78 · Cited by 2
Current and Developing Methods for Diagnosing Alzheimer's Disease
Fuller, S. J., Carrigan, N., Sohrabi, H. R., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch3 · Cited by 2
Murphy, A. J., Williamson, J. B., & Lamb, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_691 · Cited by 2
The impact of Dual-Tasking on mnestic performance in normal agingPreprint
Contemori, G., Iorio, C., & Bonato, M. (2022) · doi:10.31234/osf.io/z86tj · Cited by 2
Khan, Q. U. A., & Graff‐Radford, N. R. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch11 · Cited by 3
Chronic RNA G-quadruplex Accumulation in Aging and Alzheimer’s DiseasePreprint
Kallweit, L. M., Hamlett, E. D., Saternos, H., Gilmore, A., Granholm, A., & Horowitz, S. A. (2025) · eLife · doi:10.7554/elife.105446.2 · Cited by 2
Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer’s Disease with Dementia
Alexopoulos, P., Thierjung, N., Εconomou, P., Werle, L., Buhl, F., Kagerbauer, S. M., Papanastasiou, A. D., Grimmer, T., Gourzis, P., Berthele, A., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181088 · Cited by 1
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Guo, Z., Liu, F., Wang, F., Ou, Y., Huang, L., Hu, H., Wang, Z., Fu, Y., Gao, P., Tan, L., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240005 · Cited by 1
Chun, M. Y., Park, Y. H., Kim, H. J., Na, D. L., Kim, J. P., Seo, S. W., & Jang, H. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005793 · Cited by 1
The impact of dual-tasking on mnestic performance in normal ageing
Contemori, G., Iorio, C., & Bonato, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-96784-z · Cited by 2
Recchia, D., Michel Raymond, A., Berticat, C., & Artéro, S. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100657 · Cited by 1
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer’s disease
Yakushev, I. Y., Kriett, L., Perneczky, R., Förster, S., Schwaiger, M., Drzezga, A. E., Fellgiebel, A., & Alexopoulos, P. (2014) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 1
Tau Phosphorylation as a Therapeutic Target in Alzheimer’s Disease
Medina, M., & Ávila, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00012-5 · Cited by 1
Molecular Imaging and Precision Medicine in Dementia and Movement Disorders
Mallik, A. K., Drzezga, A. E., & Minoshima, S. (2016) · PET Clinics · doi:10.1016/j.cpet.2016.08.003 · Cited by 1
Neurodegenerative Disorders: Classification and Imaging Strategy
Haller, S., Garibotto, V., & Barkhof, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-61423-6_78-1 · Cited by 1
Fließbach, K., & Schneider, A. (2018) · Der Nervenarzt · Cited by 1
Allegri, R., Méndez, P. C., Russo, M. J., Cohen, G., Calandri, I. L., Campos, J., Nahas, F., Surace, E. I., Vázquez, S., & Sevlever, G. E. (2019) · Neurología (English Edition) · doi:10.1016/j.nrleng.2017.12.012 · Cited by 2
Criterios diagnósticos en la enfermedad demencial ¿Qué hay de nuevo?
Labos, E., Bavec, C. V., Cristalli, D. O., Deschle, F., Isaac, C. F., Dorman, G. S., Ollari, J., Rubiño, V., & Russo, M. J. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i160.460 · Cited by 4
Traits and Trammels of Tau Tracer Imaging
Villemagne, V. L., Lopresti, B. J., Doré, V., Minhas, D. S., Gogola, A., Nadkarni, N. K., Mason, N. S., Bourgeat, P., López, O. L., Ikonomović, M. D., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_6 · Cited by 1
Jellinger, K. A. (2015) · EMJ Neurology · doi:10.33590/emjneurol/10311025 · Cited by 1
Subtle postoperative cognitive disorder in preclinical Alzheimer's disease
Glasman, P., Houot, M., Migliaccio, R., Bombois, S., Gagliardi, G. P., Cacciamani, F., Habert, M. O., Dubois, B., & Epelbaum, S. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111715 · Cited by 1
Huellner, M. W., Pizzuto, D. A., Mächler, P. C., & Sekine, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-48419-4_20 · Cited by 1
Recent Updates on PET Imaging in Neurodegenerative Diseases
Kim, Y. K. (2022) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2022.0052 · Cited by 1
Murphy, A. J., Williamson, J. B., & Lamb, D. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_691-1 · Cited by 1
Li, J., Song, J., John Suckling, A., Wang, Y., Zuo, C., Zhang, C. M., Gao, J., Song, Y., Xie, A., Tan, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2744271/v1 · Cited by 1
Parada, M. D. L. P. S., Palau, F. G., Palau, F. G., Valladares‐Rodríguez, S., Rincón, M., Barroeta, M. J. R., Rodriguez, M. G., Aguado, Y. B., Blanco, A. H., Díaz-López, E., et al. (2024) · doi:10.2196/preprints.62914 · Cited by 1
A New Role for RNA G-quadruplexes in Aging and Alzheimer’s DiseasePreprint
Kallweit, L. M., Hamlett, E. D., Saternos, H., Gilmore, A., Granholm, A., & Horowitz, S. A. (2025) · eLife · doi:10.7554/elife.105446.1 · Cited by 1
Sargolzaei, S. (2015) · doi:10.25148/etd.fi15032115 · Cited by 1
Hohe Prävalenz und rasches Fortschreiten
Wolf, D. G. F. (2014) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-014-0805-7
GENÓMICA NUTRICIONAL Y ENFERMEDAD DE ALZHEIMER.
Arata, G. B., & Bellabarba, S. A. M. (2015) · Redalyc (Universidad Autónoma del Estado de México)
Degradation of Mnemonic Networks in Aging and Alzheimer’s Disease
Chhatwal, J. P. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Vellas, B. J., & Oustric, S. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.09.005
Recent Update of Clinical Drug Trials in Alzheimer’s Disease
Kang, H., & Park, K. W. (2015) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2015.4.2
How Close are We to a Readily available, Clinically Reliable Blood Test for Alzheimer's disease?
Pesini, P., & Sarasa, M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.48
Fluid biomarkers in Alzheimer's disease - current
Rosén, C., Hansson, O., Blennow, K., & Zetterberg, H. (2013)
Molecular Imaging in Alzheimer Clinical Trials
Schmidt, M. E., Matthews, D. C., & Staelens, S. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00020-4
FDG-PET in Alzheimer’s Disease
Inui, Y., Ito, K., & Kato, T. (2017) · Springer eBooks · doi:10.1007/978-4-431-55133-1_9
Alzheimer’s disease syndrome – Recognizing the complexity of dementia
Kokjohn, T. A., Serrano, G. E., & Roher, A. E. (2017) · Neurological Disorders and Therapeutics · doi:10.15761/ndt.1000116
Multimodal magnetic resonance imaging predicts regional amyloid- β burden in the brainPreprint
Rangarajan, A., Wu, M., Joseph, N. M., Karim, H. T., Laymon, C. M., Tudorascu, D., Cohen, A. D., Klunk, W. E., & Aizenstein, H. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.17.910984
Kikuchi, M., Kobayashi, K., Itoh, S., Kasuga, K., Miyashita, A., Ikeuchi, T., Yumoto, E., Fushimi, Y., Takeda, T., Manabe, S., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-129455/v1
Optimal ATN biomarkers and their role in predicting cognitive progress of mild cognitive impairmentPreprint
Song, R., Wu, X., Liu, H., Guo, D., Tang, L., Zhang, W., Feng, J., & Li, C. (2021) · Research Square · doi:10.21203/rs.3.rs-201708/v1
Kang, H. H., Park, K. W., & Kang, D. (2021) · Research Square · doi:10.21203/rs.3.rs-242396/v1
Cerebrospinal fluid biomarkers and cognition in older adults
Rådestig, M. A. (2021)
张, 宇., 金, 昊., 张, 秀., 梁, 胜., 柳, 维., 陶, 静., & 陈, 立. (2020) · Rehabilitation Medicine · doi:10.3724/sp.j.1329.2020.04008
Novel Advances in Alzheimer's Disease
Naumann, J. P. (2015) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Frequency of preclinical Alzheimer’s disease in Japanese clinical study settings: A meta‐analysis
Sato, K., Niimi, Y., Ihara, R., Suzuki, K., Iwata, A., & Iwatsubo, T. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.049334
Decoding the Epigenome of Neuronal Networks in Health and Disease
Jain, G. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7477
Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Šprung, J., Laporta, M. L., Knopman, D. S., Petersen, R. C., Mielke, M. M., Jack, C. R., Martin, D. P., Hanson, A. C., Schroeder, D. R., Schulte, P. J., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac064
Self-citationXiong, C., Lu, R., Bui, Q. V. P., Popp, B., Schindler, S. E., Shriver, L. P., Cruchaga, C., Hassenstab, J. J., Benzinger, T. L. S., Agboola, F., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5118913/v1
Polyamine biosynthesis dysregulation in Alzheimer’s disease and Down syndrome cellular modelsPreprint
Sola, A., Sandberg, A., Pham, C., Revier, A., Hebinck, M., Penney, A. L., Caviedes, P. A., Kumar, S., Granholm, A., Linseman, D. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.31.635912
Byeon, G., Byun, M. S., Yi, D., Ahn, H., Jung, G., Sohn, B. K., Jung, J. H., Chang, Y. Y., Kim, K., Choi, H., et al. (2025) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1238
What is “SNAP”? Historical Review of the Diagnosis of Alzheimer’s Disease
Ishihara, K. (2025) · Higher Brain Function Research · doi:10.2496/hbfr.45.11
Zhang, X., Caffo, B. S., Soldan, A., Pettigrew, C. A., Erus, G., Davatzikos, C. A., Morris, J. C., Benzinger, T. L. S., Johnson, S. C., Masters, C. L., et al. (2025) · Human Brain Mapping · doi:10.1002/hbm.70205
Wu, M.-J., Hsiao, I., Lin, K., Wu, Y.-M., & Wu, K.-Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01858-9 · Cited by 1
Zavecz, Z., Shah, V. D., Murillo, O. G., Vallat, R., Mander, B. A., Winer, J. R., Jagust, W. J., & Walker, M. P. (2024) · Figshare · doi:10.6084/m9.figshare.26584560
Ma, L.-Z., Tan, L., Bi, Y.-L., Shen, X.-N., Xu, W., Ma, Y.-H., Li, H.-Q., Dong, Q., & Yu, J.-T. (2020) · Figshare · doi:10.6084/m9.figshare.12114753
Huang, Y.-M., Ma, Y.-H., Gao, P.-Y., Wang, Z.-B., Huang, L., Hou, J.-H., Tan, L., & Yu, J.-T. (2023) · Figshare · doi:10.6084/m9.figshare.22619233
Wang, J., Fan, D.-Y., Li, H.-Y., He, C.-Y., Shen, Y.-Y., Zeng, G.-H., Chen, D.-W., Yi, X., Ma, Y.-H., Yu, J.-T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18482235
Wisse, L. E. M., Ravikumar, S., Ittyerah, R., Lim, S., Lane, J., Bedard, M. L., Xie, L., Das, S. R., Schuck, T., Grossman, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15033187
Wisse, L. E. M., de Florès, R., Xie, L., Das, S. R., McMillan, C. T., Trojanowski, J. Q., Grossman, M., Lee, E. B., Irwin, D., Yushkevich, P. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14600460
Bousiges, O., Cretin, B., Battista, L., Schaeffer‐Agalède, C., Philippi, N., Hamied, L., Ravier, A., Demuynck, C., Muller, C., & Blanc, F. (2026) · GeroScience · doi:10.1007/s11357-026-02185-z
Si, W., Ma, X., Lin, J., Xu, T., Wang, R., Zhu, A., & Cao, W. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106412
Etude préclinique et clinique de la phase précoce de la maladie d'Alzheimer
Epelbaum, S. (2015) · theses.fr (ABES) · doi:10.70675/ea81e5c2z5032z4474z9f96z59f62125a629
Tomadesso, C. (2018) · theses.fr (ABES) · doi:10.70675/7fad6418zff81z49c7z984dz63aa2e44d7fc
Yang, J., Wang, J., Chai, W., Zhang, L., Li, A., Lan, G., Jiang, M., Fan, X., 杨洪杰, Li, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71397
Yamada, K., Kurihara, M., Akitomi, Y., Sato, K., Shimasaki, R., Hatano, K., Bannai, T., Suzuki, F., Furuta, K., Tokumaru, A. M., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70374
Champetier, P., Herreros, C. A., Pereira, F. R., Herzog, R. A., Chaumon, M., Houot, M., Locatelli, M., Kas, A., Habert, M., Teichmann, M., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71514 · Cited by 1
Frontal Release Signs and Future Decline in Research Participants With Intact Cognition
Bojarski, L., Jicha, G. A., Coskun, E. P., Schmitt, F. A., Eldik, L. J. V., & Abner, E. L. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.17060
Rapport 26-07. De la clinique à la neuropsychologie
Lechevalier, B., Laurent, B., Dubois, B., & Viader, F. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.06.011
Le concept de sujet à risque dans la maladie d’Alzheimer
Villain, N. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.06.015
Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta‐Analysis
Javed, M. N., Khan, S. M., Mustafa, S., Mujtaba, A., Amin, H., Azhar, N. A., Hameed, A., Zayed, A., Khalid, M., & Hussain, J. M. (2026) · Brain and Behavior · doi:10.1002/brb3.71643
Contribution of G4 Structure to Alzheimer’s Disease and Tau Pathology
Kallweit, L. M. (2026) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2026.63
Haller, S., Barkhof, F., & Oliveira, T. G. (2026) · Springer eBooks · doi:10.1007/978-3-319-61423-6_64-2
Metadata
- Authors
- Jack, C. R., Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., & Petersen, R. C.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Jack, Clifford R.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-04-09
- Volume
- 71
- Issue
- 6
- Pages
- 765-775
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC3586223
- OpenAlex
- W2044429455
- Cited by
- 602
- References
- 71
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 21 · 2023: 28 · 2022: 29 · 2021: 40 · 2020: 33 · 2019: 40 · 2018: 44 · 2017: 60 · 2016: 80 · 2015: 65 · 2014: 63 · 2013: 51 · 2012: 10
- FWCI
- 27.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- Mayo Foundation for Medical Education and Research
- National Institute on Aging (R01AG11378, P50‐AG16574, U01AG006786, R01AG011378, R01AG041851, P50AG016574)
- National Center for Research Resources (C06RR018898)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- preclinical Alzheimer's disease, NIA-AA criteria, Pittsburgh compound B PET, cerebral amyloidosis, FDG-PET, hippocampal volume, neurodegeneration biomarkers, cognitively normal older adults, diagnostic classification
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Brain, Cognition Disorders, Female, Humans, Longitudinal Studies, Male, Mental Status Schedule, Neuropsychological Tests, Thiazoles, United States, Biomarkers, Disease Progression, Fluorodeoxyglucose F18, Positron-Emission Tomography, National Institute on Aging (U.S.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
